CIRCULATION RESEARCH

Scope & Guideline

Advancing cardiovascular science through innovative research.

Introduction

Delve into the academic richness of CIRCULATION RESEARCH with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN0009-7330
PublisherLIPPINCOTT WILLIAMS & WILKINS
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1953 to 2024
AbbreviationCIRC RES / Circ.Res.
Frequency24 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressTWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103

Aims and Scopes

Circulation Research is dedicated to advancing cardiovascular science through innovative research that spans basic, translational, and clinical domains. The journal focuses on the molecular and cellular mechanisms underlying cardiovascular health and disease, including the intersection of cardiovascular and systemic diseases.
  1. Cardiovascular Biology and Physiology:
    Research exploring the fundamental biological processes and physiological mechanisms that govern cardiovascular function, including cardiac muscle function, endothelial biology, and vascular dynamics.
  2. Pathophysiology of Cardiovascular Diseases:
    Studies investigating the molecular and cellular mechanisms involved in various cardiovascular diseases such as heart failure, myocardial infarction, atherosclerosis, and arrhythmias.
  3. Translational Research:
    Research aimed at translating basic scientific discoveries into clinical applications, including the development of new therapeutic strategies and interventions for cardiovascular diseases.
  4. Innovative Therapeutic Approaches:
    Exploration of novel therapeutic modalities, including gene therapy, stem cell therapy, and advanced biomaterials for cardiovascular repair and regeneration.
  5. Environmental and Lifestyle Factors in Cardiovascular Health:
    Research assessing the impact of environmental exposures, lifestyle choices, and metabolic factors on cardiovascular health and disease progression.
  6. Immunology and Inflammation in Cardiovascular Diseases:
    Investigations into the roles of immune cells and inflammatory processes in the development and progression of cardiovascular conditions.
  7. Genomics and Personalized Medicine:
    Studies leveraging genetic and genomic insights to understand individual variations in cardiovascular disease risk and response to therapies.
Circulation Research has witnessed significant shifts in research focus, with several emerging themes gaining prominence in recent publications. These trends reflect the journal's commitment to addressing contemporary challenges in cardiovascular science.
  1. Single-Cell and Multi-Omics Approaches:
    An increasing number of studies are utilizing single-cell RNA sequencing and multi-omics approaches to unravel the complex cellular heterogeneity and molecular mechanisms underlying cardiovascular diseases.
  2. Cardiac Regeneration and Repair:
    Research into cardiac regeneration, including the potential of stem cells and engineered tissues, is gaining traction, driven by the need for innovative treatments for heart failure and myocardial infarction.
  3. Microbiome and Cardiovascular Interactions:
    Emerging evidence highlights the significant role of gut microbiota in modulating cardiovascular health, with studies exploring how microbial metabolites influence cardiac function and disease.
  4. Inflammation and Immunology:
    There is a growing focus on the role of inflammation and immune responses in cardiovascular diseases, with research investigating the interactions between immune cells and cardiovascular tissues.
  5. Mitochondrial Biology and Metabolism:
    Increased attention is being given to mitochondrial function and bioenergetics in the context of cardiovascular health, emphasizing the importance of metabolic pathways in disease mechanisms.
  6. Artificial Intelligence and Machine Learning:
    The application of artificial intelligence and machine learning techniques to analyze complex cardiovascular data sets is on the rise, aiding in risk prediction and personalized treatment strategies.

Declining or Waning

While Circulation Research continues to evolve, certain traditional themes have seen a decline in focus over recent years, reflecting shifts in research priorities and emerging trends in cardiovascular science.
  1. Traditional Pharmacology:
    Research centered on conventional pharmacological interventions for cardiovascular diseases has become less prominent, as the field increasingly embraces innovative therapeutic strategies such as gene therapy and personalized medicine.
  2. Basic Animal Models of Cardiovascular Disease:
    There is a noticeable decline in studies utilizing classical animal models in favor of more sophisticated models, including human-induced pluripotent stem cell (hiPSC) systems and organ-on-a-chip technologies.
  3. Purely Descriptive Studies:
    The journal has moved away from purely descriptive studies of cardiovascular conditions, focusing instead on mechanistic insights and translational applications that provide clear therapeutic implications.
  4. Static Imaging Techniques:
    The reliance on traditional static imaging techniques is diminishing as dynamic and advanced imaging modalities, such as multimodal imaging and real-time imaging, become more prevalent in cardiovascular research.

Similar Journals

HEART AND VESSELS

Transforming Heart Health Through Scholarly Excellence
Publisher: SPRINGERISSN: 0910-8327Frequency: 12 issues/year

HEART AND VESSELS is a prominent peer-reviewed journal published by SPRINGER, dedicated to advancing the fields of cardiology and cardiovascular medicine. With its ISSN 0910-8327 and E-ISSN 1615-2573, this esteemed journal encompasses a broad range of topics pertinent to heart health, vascular function, and associated therapies, making it an essential resource for researchers, clinicians, and healthcare professionals alike. Based in Japan and operating since 1985, HEART AND VESSELS has consistently maintained a Q2 ranking in the 2023 category quartiles, highlighting its relevance and impact in the cardio domain. Although it does not offer open access, the journal ensures high-quality publications that contribute significantly to the academic and clinical understanding of cardiovascular health. With over three decades of continuous scholarly contribution, HEART AND VESSELS serves as a vital platform for disseminating cutting-edge research and fostering innovative practices in the management of cardiovascular diseases.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Unveiling breakthroughs in cardiovascular disease treatment and management.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0160-2446Frequency: 12 issues/year

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, published by LIPPINCOTT WILLIAMS & WILKINS, is a leading peer-reviewed journal dedicated to the exploration and advancement of pharmacological therapies related to cardiovascular diseases. With its ISSN 0160-2446 and E-ISSN 1533-4023, this esteemed journal has been at the forefront of cardiovascular research since its inception in 1979, continuously offering insights until 2024. It holds a commendable position in the 2023 category quartiles, classified as Q2 in both Cardiology and Cardiovascular Medicine, as well as Medicine (miscellaneous) and Pharmacology, showcasing its significance within these fields. The journal presents a unique platform for researchers, health professionals, and students to disseminate their findings, fostering an environment of knowledge growth and collaboration in cardiovascular pharmacology. Readers can expect to find high-quality articles that contribute to the body of knowledge in cardiovascular therapies, ensuring they remain informed of the latest advancements and clinical practices. Discover more about this influential publication and its commitment to enhancing cardiovascular health.

Nature Reviews Cardiology

Unveiling Insights that Shape Cardiac Care
Publisher: NATURE PORTFOLIOISSN: 1759-5002Frequency: 12 issues/year

Nature Reviews Cardiology, published by NATURE PORTFOLIO, stands as a premier academic journal in the field of cardiology and cardiovascular medicine, boasting an impressive impact factor and a distinguished ranking of #1 out of 387 in Scopus. Since its inception in 2009, this exemplary journal has continuously delivered cutting-edge reviews and insights, supporting researchers, healthcare professionals, and students in navigating the complex landscape of cardiovascular health. With a commitment to providing open access and disseminating rigorous research, Nature Reviews Cardiology captures the forefront of innovation and scholarship, critical for facilitating advancements in cardiovascular science and clinical practice. Situated in the United Kingdom and with a vibrant global readership, this journal perpetuates academic excellence, ensuring accessibility to the latest findings that shape prevention, diagnosis, and treatment strategies in cardiology through to 2024 and beyond.

BASIC RESEARCH IN CARDIOLOGY

Driving innovation in cardiac research and clinical practice.
Publisher: SPRINGER HEIDELBERGISSN: 0300-8428Frequency: 6 issues/year

BASIC RESEARCH IN CARDIOLOGY, published by SPRINGER HEIDELBERG, is an esteemed peer-reviewed journal dedicated to advancing the field of cardiology and cardiovascular medicine since 1973. With a strong emphasis on the latest breakthroughs in basic and translational research, this journal offers a platform for high-quality, impactful studies that contribute to our understanding of cardiac function and related physiological processes. Currently ranked in the Q1 category in Cardiology and Cardiovascular Medicine, as well as Physiology and Medical Physiology, BASIC RESEARCH IN CARDIOLOGY is recognized as a leading journal within these disciplines, boasting impressive Scopus ranks that place it in the top tiers of global research output. While it does not offer open access, its contributions are pivotal for researchers, clinicians, and students seeking to stay abreast of cutting-edge discoveries and methodologies in cardiovascular science. With its commitment to scholarly excellence, this journal plays a critical role in shaping the future of cardiac research and clinical practice.

CURRENT PROBLEMS IN CARDIOLOGY

Advancing Insights in Cardiovascular Challenges
Publisher: MOSBY-ELSEVIERISSN: 0146-2806Frequency: 12 issues/year

CURRENT PROBLEMS IN CARDIOLOGY is a leading peer-reviewed journal published by MOSBY-ELSEVIER, dedicated to advancing the field of cardiology through comprehensive analyses of contemporary challenges faced by cardiovascular practitioners. With its ISSN 0146-2806 and E-ISSN 1535-6280, this esteemed journal has been a crucial resource for researchers, clinicians, and students alike since its inception in 1976, and continues to publish groundbreaking studies and reviews up until 2024. As a testament to its scholarly impact, CURRENT PROBLEMS IN CARDIOLOGY boasts a prestigious Q1 ranking in both Cardiology and Cardiovascular Medicine, as well as in the broader category of Medicine (miscellaneous) in the 2023 metrics, positioning it among the top journals in its field. With a Scopus ranking of #127 out of 387 in Cardiology, and a 67th percentile ranking, it remains a vital platform for disseminating high-quality research that addresses critical issues in cardiovascular health. Researchers and practitioners looking to stay at the forefront of cardiac medicine will find this journal an indispensable tool for informed decision-making and practice improvement.

Frontiers in Cardiovascular Medicine

Empowering Researchers to Transform Cardiovascular Care.
Publisher: FRONTIERS MEDIA SAISSN: 2297-055XFrequency: 1 issue/year

Frontiers in Cardiovascular Medicine is a leading open-access journal published by FRONTIERS MEDIA SA, dedicated to advancing research in the field of cardiology and cardiovascular medicine. Since its inception in 2014, the journal has become a vital platform for the dissemination of high-quality research, boasting a commendable Q2 rank in the 2023 category for Cardiology and Cardiovascular Medicine. With a focus on promoting innovative studies and clinical insights, Frontiers in Cardiovascular Medicine facilitates open access to its content, allowing researchers, healthcare professionals, and students from around the globe to engage with the latest findings which are critical for the advancement of cardiovascular health. The journal's significant presence in the academic landscape, as indicated by its Scopus ranking (161/387 and 58th percentile), underscores its importance as a research outlet in this essential field. Located in Lausanne, Switzerland, the journal continues to support the global cardiovascular community by encouraging collaboration and knowledge sharing to address the challenges faced in cardiovascular medicine today.

CIRCULATION

Leading the Charge in Heart Health Research.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0009-7322Frequency: 50 issues/year

CIRCULATION is a premier journal in the field of cardiology and cardiovascular medicine, published by Lippincott Williams & Wilkins. With a distinguished history dating back to 1950, the journal has consistently been at the forefront of critical research, showcasing significant advancements and discoveries in cardiovascular health. It holds a remarkable Q1 ranking in both the fields of Cardiology and Physiology (medical) according to the 2023 category quartiles, demonstrating its influential role among the top publications in these disciplines. With an impressive Scopus ranking, placed 3rd out of 387 in Cardiology and 2nd out of 113 in Physiology, CIRCULATION is essential reading for researchers, practitioners, and students passionate about advancing their understanding of heart health and related medical sciences. Although the journal is not open access, it continues to foster scholarly exchange and innovation in cardiovascular research, making it an indispensable resource for quality insights and groundbreaking studies.

American Journal of Cardiovascular Drugs

Fostering Excellence in Cardiovascular Drug Research
Publisher: ADIS INT LTDISSN: 1175-3277Frequency: 6 issues/year

American Journal of Cardiovascular Drugs, published by ADIS INT LTD, is a premier peer-reviewed journal dedicated to the field of cardiology and cardiovascular medicine. With an ISSN of 1175-3277 and an E-ISSN of 1179-187X, this esteemed journal has established itself as a crucial platform for disseminating high-quality research since its inception in 2001. It holds a significant position in its domain, ranking in the second quartile (Q2) across several categories including Cardiology, Medicine (miscellaneous), and Pharmacology (medical) for the year 2023. With its Scopus ranks placing it in the 81st percentile for Cardiology and 77th percentile for Pharmacology, the journal is highly regarded among professionals, researchers, and students alike. While it is not an open-access journal, its comprehensive articles and systematic reviews provide an in-depth exploration of cardiovascular drug therapy, therapeutic advancements, and clinical practices, making it an invaluable resource for anyone invested in the future of cardiovascular health.

Journal of Cardiovascular Development and Disease

Connecting global scholars in the pursuit of cardiovascular excellence.
Publisher: MDPIISSN: Frequency: 12 issues/year

Journal of Cardiovascular Development and Disease, an esteemed publication by MDPI, has been a dedicated platform for disseminating cutting-edge research since its inception in 2014. Based in Switzerland, this Open Access journal not only provides unrestricted access to its content but also fosters global collaboration among scholars focusing on cardiovascular health and disease development. With an impressive focus classified as Q1 in Pharmacology, Toxicology and Pharmaceutics for 2023, it attracts a diverse range of interdisciplinary research, supporting advancements in pharmacological applications relevant to cardiac conditions. The journal's ongoing convergence through 2024 highlights its commitment to the evolving landscape of cardiovascular research, making it a vital resource for researchers, professionals, and students alike who are keen to contribute to and learn from significant developments in this critical field.

CARDIOVASCULAR RESEARCH

Connecting research to real-world cardiovascular solutions.
Publisher: OXFORD UNIV PRESSISSN: 0008-6363Frequency: 18 issues/year

CARDIOVASCULAR RESEARCH, published by Oxford University Press, is a premier academic journal dedicated to the evolving field of cardiology and cardiovascular medicine. With a remarkable impact factor reflecting its significant contribution to the scientific community, this journal maintains a Q1 ranking in both Cardiology and Physiology categories, demonstrating its commitment to publishing high-quality research that influences clinical practices and healthcare outcomes. Established in 1967, the journal has consistently provided a platform for innovative studies and reviews, aiming to advance our understanding of cardiovascular physiology and pathology. Researchers, professionals, and students will find published articles crucial for their work, as the journal covers a broad spectrum of topics including molecular biology, genetics, and clinical studies. While currently not offering open access options, CARDIOVASCULAR RESEARCH remains accessible through institutional and individual subscriptions, ensuring that the latest findings are available to those in the cardiovascular science community.